Tin tức & Cập nhật
Xem bài viết Bệnh nhiễm khuẩn
Xem
Chỉ hiển thị Multimedia

Regdanvimab for COVID-19 effective against Delta variant
13 Jan 2023
The neutralizing antibody regdanvimab appears to be useful in the treatment of mild-to-moderate COVID-19, with a recent study showing that the drug may prevent disease worsening in patients, including those infected with the Delta variant.
13 Jan 2023

Lower plasma ACE2 levels may partially mediate COVID-19 risks in overweight/obesity or low socioeconomic position
10 Jan 2023
bởiSarah Cheung
Lower plasma angiotensin-converting enzyme 2 (ACE2) levels may partially mediate COVID-19 risks in individuals with overweight/obesity or low socioeconomic position (SEP; referring to low educational attainment), according to a large-scale Mendelian randomization study conducted by researchers at the University of Hong Kong (HKU) and the Chinese University of Hong Kong (CUHK).
10 Jan 2023






